What is Toxicology

Toxicology is the scientific study of the effects of chemical, biological, and physical agents on living systems, particularly humans. It involves understanding the nature, mechanisms, and extent of harmful effects caused by various agents, including chemicals, drugs, and environmental pollutants. Toxicologists assess the risk and safety of these substances, aiming to protect public health by identifying potential hazards and ensuring safe exposure to these compounds.  

 

Medical device toxicology focuses on evaluating the safety of materials used in medical devices that come into contact with the human body. This involves assessing the potential for these materials to cause adverse biological reactions, such as systemic toxicity, carcinogenicity, or reproductive toxicity. Regulatory bodies, like the FDA, require rigorous toxicity testing and biocompatibility evaluation of medical devices to protect patient health and ensure the safety and effectiveness of these products.  

 

An often-used tool in the biocompatibility evaluation is a toxicological risk assessment (TRA) to ensure that medical devices are biocompatible and safe for their intended use. A toxicological risk assessment systematically evaluates the potential harm that chemicals or substances may cause to the patient during use of the device by considering factors such as the chemical composition of the device, the duration and type of exposure, and the potential for leaching of harmful substances. The toxicological risk assessment process helps identify and quantify risks, ensuring that any potential adverse effects are understood and managed effectively. Having a scientifically sound, well-conducted toxicological risk assessment is crucial for the device biocompatibility evaluation and regulatory submission as it provides a comprehensive and accurate understanding of the potential hazards associated with a device. This thorough evaluation is necessary to ensure the safety of devices. Inadequate or poorly conducted assessments can lead to overlooked risks, resulting in adverse health outcomes, regulatory non-compliance, and potential legal liabilities. Therefore, meticulous and robust toxicological risk assessments are vital for making informed decisions that safeguard health and safety. 

 

Your Toxicology Experts

MCRA’s toxicology and biocompatibility team are experts in providing toxicity services, including toxicological risk assessments, because of our extensive experience, deep technical expertise, and comprehensive understanding of the global regulatory landscape. Our team of toxicologists, biocompatibility specialists, and analytical chemist work collaboratively to deliver rigorous assessments that meet the highest scientific and regulatory standards. We employ state of the art methodologies to our toxicological evaluation and utilize your full biocompatibility package to provide a robust package for regulatory submission. Our commitment to precision, thoroughness, and regulatory compliance ensures that our assessments are reliable and trusted by clients across various therapies, including orthopedics, cardiology, neurology devices and many more.  
 

Contact A Toxicology Expert

 

Toxicology Solutions for Europe and the MDR

A specific requirement for the European Medical Device Regulation (EU MDR) includes a rationale for including substances that are classified as Class 1A and 1B carcinogenic, mutagenic, or toxic for reproduction (CMR substances) at a concentration above 0.1% in the medical device. These benefit-risk assessments need to discuss the benefits of the CMR substance, along with the risk of toxicity, compared to alternative substances. Our team has extensive knowledge and experience in developing these assessments for the EU MDR and is an author in a series of recent publications that review the reproductive toxicity and carcinogenic potential of Cobalt-containing alloys and evaluate their benefits and risks.

 

Toxicology Services Offered

Our toxicology team specializes in obtaining regulatory approvals, resolving denial orders, and addressing inquiries from the US FDA and EU notified bodies, including compliance with standards such as ISO 10993 series, ISO 14971, ISO 18562 series, ICH M7, and EU MDR. Some of our specific services include:

  • Toxicological risk assessment (TRA) conducted according to ISO 10993-17 and ISO 21726 guideline 
  • Gas pathway TRAs conducted according to ISO 18562 guidelines
  • Author and/or signatory review of BEP and BER 
  • Benefit-risk assessment for Class 1A and 1B CMR substances for EU MDR submissions 
  • Paper-based toxicity or carcinogenicity rationale 

 

Contact A Toxicology Expert

 

 

Meet Our Toxicology Team

View Contact
Sharlee More, Ph.D., DABT

Sharlee More, Ph.D., DABT

Associate Director, Toxicology, Regulatory Affairs
View Contact
Eric M. Sussman, Ph.D.

Eric M. Sussman, Ph.D.

Director, Biocompatibility